Viral metagenomics and blood safety

Transfusion Clinique et Biologique

Volumn 23, Issue 1, 2016, Pages 28-38

  Sauvage, V ^a   Eloit, M ^b,c  

^a INSTITUT NATIONAL DE LA TRANSFUSION SANGUINE   (France)

^b PathoQuest   (France)

^c INSTITUT PASTEUR   (France)

Author keywords

Blood safety; Blood borne viruses; Emerging viruses; High throughput sequencing; Viral discovery; Viral metagenomics

Indexed keywords

BLOOD COMPONENT; BLOOD SAFETY; BLOOD TRANSFUSION; FAMILY; FATALITY; HIGH THROUGHPUT SEQUENCING; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN TISSUE; HUMAN VERSUS ANIMAL COMPARISON; LEUKOCYTE; METAGENOMICS; PATHOGENESIS; PLASMA; RECIPIENT; VIRUS GENOME; ADVERSE EFFECTS; BIOLOGY; BLOOD; COMMUNICABLE DISEASES, EMERGING; GENE LIBRARY; GENETICS; HEALTH SURVEY; IMMUNOCOMPROMISED PATIENT; METAGENOME; PROCEDURES; SPECIMEN HANDLING; TRANSMISSION; VIREMIA; VIROLOGY; VIRUS GENE; VIRUS INACTIVATION;

VIRUS DNA; VIRUS RNA;

BLOOD SAFETY; BLOOD TRANSFUSION; COMMUNICABLE DISEASES, EMERGING; COMPUTATIONAL BIOLOGY; DNA, VIRAL; GENE LIBRARY; GENES, VIRAL; HIGH-THROUGHPUT NUCLEOTIDE SEQUENCING; HUMANS; IMMUNOCOMPROMISED HOST; METAGENOME; METAGENOMICS; POPULATION SURVEILLANCE; RNA, VIRAL; SPECIMEN HANDLING; VIREMIA; VIROLOGY; VIRUS INACTIVATION;

EID: 84958170054     PISSN: 12467820     EISSN: 19538022     Source Type: Journal    
DOI: 10.1016/j.tracli.2015.12.002     Document Type: Article

References (104)

1. Barros A.E., Gomes A.M., do Bonfim C.V. Viral inactivation in hemotherapy: systematic review on inactivators with action on nucleic acids. Rev Bras Hematol Hemoter 2012, 34:231-235.
2. Hauser L., Roque-Afonso A.M., Beylouné A., Simonet M., Deau Fischer B., Burin des Roziers N., et al. Hepatitis E transmission by transfusion of Intercept blood system-treated plasma. Blood 2014, 123:796-797.
3. Stramer S.L., Hollinger F.B., Katz L.M., Kleinman S., Metzel P.S., Gregory K.R., et al. Emerging infectious disease agents and their potential threat to transfusion safety. Transfusion 2009, 49:1S-29S.
4. Zhang W., Ke L., Changqing L., Zhang Y., Li W. Parvovirus B19 V DNA contamination in Chinese plasma and plasma derivatives. J Transl Med 2012, 10:194.
5. Jones K.E., Patel N.G., Levy M.A., Storeygard A., Balk D., Gittleman J., et al. Global trends in emerging infectious diseases. Nature 2008, 451:990-993.
6. Cleaveland S., Haydon D.T., Taylor L. Overviews of pathogen emergence: which pathogens emerge, when and why?. Curr Top Microbiol Immunol 2007, 315:85-111. [Review].
7. Anthony S.J., Epstein J.H., Murray K.A., Navarrete-Macias I., Zambrana-Torrelio C.M., Solovyov A., et al. A strategy to estimate unknown viral diversity in mammals. MBio 2013, 4:e00598-e613.
8. Wolfe N.D., Dunavan C.P., Diamond J. Origins of major human infectious diseases. Nature 2007, 447:279-283.
9. Lipkin W.I. The changing face of pathogen discovery and surveillance. Nat Rev Microbiol 2013, 11:133-141.
10. Stramer S.L. Current perspectives in transfusion-transmitted infectious diseases: emerging and re-emerging infections. ISBT Sci Ser 2014, 9:30-36.
11. Tang P., Chiu C. Metagenomics for the discovery of novel human viruses. Future Microbiol 2010, 5:177-189.
12. Ng T.F., Marine R., Wang C., Simmonds P., Kapusinszky B., Bodhidatta L., et al. High variety of known and new RNA and DNA viruses of diverse origins in untreated sewage. J Virol 2012, 86:12161-12175.
13. Labonté J.M., Suttle C.A. Previously unknown and highly divergent ssDNA viruses populate the oceans. ISME J 2013, 7:2169-2177.
14. Minot S., Sinha R., Chen J., Li H., Keilbaugh S.A., Wu G.D., et al. The human gut virome: inter-individual variation and dynamic response to diet. Genome Res 2011, 21:1616-1625.
15. Lysholm F., Wetterbom A., Lindau C., Darban H., Bjerkner A., Fahlander K., et al. Characterization of the viral microbiome in patients with severe lower respiratory tract infections, using metagenomic sequencing. PLoS One 2012, 7:e30875.
16. Foulongne V., Sauvage V., Hebert C., Dereure O., Cheval J., Gouilh M.A., et al. Human skin microbiota: high diversity of DNA viruses identified on the human skin by high throughput sequencing. PLoS One 2012, 7:e38499.
17. Phan T.G., Kapusinszky B., Wang C., Rose R.K., Lipton H.L., Delwart E.L. The fecal viral flora of wild rodents. PLoS Pathog 2011, 7:e1002218.
18. Shan T., Li L., Simmonds P., Wang C., Moeser A., Delwart E. The fecal virome of pigs on a high-density farm. J Virol 2011, 85:11697-11708.
19. Dacheux L., Cervantes-Gonzalez M., Guigon G., Thiberge J.M., Vandenbogaert M., Maufrais C., et al. A preliminary study of viral metagenomics of French bat species in contact with humans: identification of new mammalian viruses. PLoS One 2014, 9:e87194.
20. Feng H., Shuda M., Chang Y., Moore P.S. Clonal integration of a polyomavirus in human Merkel cell carcinoma. Science 2008, 319:1096-1100.
21. Xu B., Liu L., Huang X., Ma H., Zhang Y., Du Y., et al. Metagenomic analysis of fever, thrombocytopenia and leukopenia syndrome (FTLS) in Henan Province, China: discovery of a new bunyavirus. PLoS Pathog 2011, 7:e1002369.
22. Towner J.S., Sealy T.K., Khristova M.L., Albariño C.G., Conlan S., Reeder S.A., et al. Newly discovered Ebola virus associated with hemorrhagic fever outbreak in Uganda. PLoS Pathog 2008, 4:e1000212.
23. Grard G., Fair J.N., Lee D., Slikas E., Steffen I., Muyembe J.J., et al. A novel rhabdovirus associated with acute hemorrhagic fever in central Africa. PLoS Pathog 2012, 8:e1002924.
24. Mishra N., Pereira M., Rhodes R.H., An P., Pipas J.M., Jain K., et al. Identification of a novel polyomavirus in a pancreatic transplant recipient with retinal blindness and vasculitic myopathy. J Infect Dis 2014, 210:1595-1599.
25. Palacios G., Druce J., Du L., Tran T., Birch C., Briese T., et al. A new arenavirus in a cluster of fatal transplant-associated diseases. N Engl J Med 2008, 358:991-998.
26. Barzon L., Lavezzo E., Costanzi G., Franchin E., Toppo S., Palù G. Next-generation sequencing technologies in diagnostic virology. J. Clin. Virol 2013, 58:346-350.
27. Quiñones-Mateu M.E., Avila S., Reyes-Teran G., Martinez M.A. Deep sequencing: becoming a critical tool in clinical virology. J Clin Virol 2014, 61:9-19.
28. Onions D. Overview of emerging technologies to detect adventitious agents. PDA J Pharm Sci Technol 2011, 65:654-659.
29. Cabannes E., Hébert C., Eloit M. Whole genome: next-generation sequencing as a virus safety test for biotechnological products. PDA J Pharm Sci Technol 2014, 68:631-638.
30. Onions D., Côté C., Love B., Toms B., Koduri S., Armstrong A., et al. Ensuring the safety of vaccine cell substrates by massively parallel sequencing of the transcriptome. Vaccine 2011, 29:7117-7121.
31. Onions D. Massively parallel sequencing: a new tool in virus discovery and vaccine safety. Bull Mem Acad R Med Belg 2011, 166:404-406.
32. Gagnieur L., Cheval J., Gratigny M., Hébert C., Muth E., Dumarest M., et al. Unbiased analysis by high throughput sequencing of the viral diversity in fetal bovine serum and trypsin used in cell culture. Biologicals 2014, 42:145-152.
33. Gagnieur L., Cheval J., Cochet M., Breard E., Gratigny M., Hébert C., et al. Analysis by high throughput sequencing of Specific Pathogen Free eggs. Biologicals 2014, 42:218-219.
34. Dumarest M., Muth E., Cheval J., Gratigny M., Hébert C., Gagnieur L., et al. Viral diversity in swine intestinal mucus used for the manufacture of heparin as analyzed by high-throughput sequencing. Biologicals 2015, 43:31-36.
35. Victoria J.G., Wang C., Jones M.S., Jaing C., McLoughlin K., Gardner S., et al. Viral nucleic acids in live-attenuated vaccines: detection of minority variants and an adventitious virus. J Virol 2010, 84:6033-6040.
36. Cheval J., Sauvage V., Frangeul L., Dacheux L., Guigon G., Dumey N., et al. Evaluation of high-throughput sequencing for identifying known and unknown viruses in biological samples. J Clin Microbiol 2011, 49:3268-3275.
37. Solonenko S.A., Ignacio-Espinoza J.C., Alberti A., Cruaud C., Hallam S., Konstantinidis K., et al. Sequencing platform and library preparation choices impact viral metagenomes. BMC Genomics 2013, 14:320.
38. Frey K.G., Herrera-Galeano J.E., Redden C.L., Luu T.V., Servetas S.L., Mateczun A.J., Mokashi V.P., Bishop-Lilly K.A. Comparison of three next-generation sequencing platforms for metagenomic sequencing and identification of pathogens in blood. BMC Genomics 2014, 15:96.
39. Kohl C., Brinkmann A., Dabrowski P.W., Radonić A., Nitsche A., Kurth A. Protocol for metagenomic virus detection in clinical specimens. Emerg Infect Dis 2015, 21:48-57.
40. Li L., Deng X., Mee E.T., Collot-Teixeira S., Anderson R., Schepelmann S., Minor P.D., Delwart E. Comparing viral metagenomics methods using a highly multiplexed human viral pathogens reagent. J Virol Methods 2015, 213:139-146.
41. Thurber R.V., Haynes M., Breitbart M., Wegley L., Rohwer F. Laboratory procedures to generate viral metagenomes. Nat Protoc 2009, 4:470-483.
42. Hall R.J., Wang J., Todd A.K., Bissielo A.B., Yen S., Strydom H., et al. Evaluation of rapid and simple techniques for the enrichment of viruses prior to metagenomic virus discovery. J Virol Methods 2014, 195:194-204.
43. Rosseel T., Ozhelvaci O., Freimanis G., Van Borm S. Evaluation of convenient pretreatment protocols for RNA virus metagenomics in serum and tissue samples. J Virol Methods 2015, 222:72-80.
44. Rosenberg R. Detecting the emergence of novel, zoonotic viruses pathogenic to humans. Cell Mol Life Sci 2015, 72:1115-1125.
45. Reyes G.R., Kim J.P. Sequence-independent, single-primer amplification (SISPA) of complex DNA populations. Mol Cell Probes 1991, 5:473-481.
46. Allander T., Emerson S.U., Engle R.E., Purcell R.H., Bukh J. A virus discovery method incorporating DNase treatment and its application to the identification of two bovine parvovirus species. Proc Natl Acad Sci U S A 2001, 98:11609-11614.
47. Berthet N., Reinhardt A.K., Leclercq I., van Ooyen S., Batéjat C., Dickinson P., et al. Phi29 polymerase based random amplification of viral RNA as an alternative to random RT-PCR. BMC Mol Biol 2008, 9:77.
48. Pyrc K., Jebbink M.F., Berkhout B., van der Hoek L. Detection of new viruses by VIDISCA. Virus discovery based on cDNA-amplified fragment length polymorphism. Methods Mol Biol 2008, 454:73-89.
49. Boros Á., Nemes C., Pankovics P., Kapusinszky B., Delwart E., Reuter G. Identification and complete genome characterization of a novel picornavirus in turkey (Meleagris gallopavo). J Gen Virol 2012, 93:2171-2182.
50. Coffey L.L., Page B.L., Greninger A.L., Herring B.L., Russell R.C., Doggett S.L., et al. Enhanced arbovirus surveillance with deep sequencing: Identification of novel rhabdoviruses and bunyaviruses in Australian mosquitoes. Virology 2014, 448:146-158.
51. Rosseel T., Scheuch M., Höper D., De Regge N., Caij A.B., Vandenbussche F., et al. DNase SISPA-next generation sequencing confirms Schmallenberg virus in Belgian field samples and identifies genetic variation in Europe. PLoS One 2012, 7:e41967.
52. Victoria J.G., Kapoor A., Li L., Blinkova O., Slikas B., Wang C., et al. Metagenomic analyses of viruses in stool samples from children with acute flaccid paralysis. J Virol 2009, 83:4642-4651.
53. Briese T., Paweska J.T., McMullan L.K., Hutchison S.K., Street C., Palacios G., et al. Genetic detection and characterization of Lujo virus, a new hemorrhagic fever-associated arenavirus from southern Africa. PLoS Pathog 2009, 5:e1000455.
54. McMullan L.K., Frace M., Sammons S.A., Shoemaker T., Balinandi S., Wamala J.F., et al. Using next generation sequencing to identify yellow fever virus in Uganda. Virology 2012, 422:1-5.
55. Bodemer C., Sauvage V., Mahlaoui N., Cheval J., Couderc T., Leclerc-Mercier S., et al. Live rubella virus vaccine long-term persistence as an antigenic trigger of cutaneous granulomas in patients with primary immunodeficiency. Clin Microbiol Infect 2014, 20:O656-O663.
56. Sauvage V., Ar Gouilh M., Cheval J., Muth E., Pariente K., Burguiere A., et al. A member of a new Picornaviridae genus is shed in pig feces. J Virol 2012, 86:10036-10046.
57. Frémond M.L., Pérot P., Muth E., Cros G., Dumarest M., Mahlaoui N., et al. Next-generation sequencing for diagnosis and tailored therapy: a case report of astrovirus-associated progressive encephalitis. J Pediatric Infect Dis Soc 2015, 4:e53-e57.
58. Bachem C.W., van der Hoeven R.S., de Bruijn S.M., Vreugdenhil D., Zabeau M., Visser R.G. Visualization of differential gene expression using a novel method of RNA fingerprinting based on AFLP: analysis of gene expression during potato tuber development. Plant J 1996, 9:745-753.
59. van der Hoek L., Pyrc K., Jebbink M.F., Vermeulen-Oost W., Berkhout R.J., Wolthers K.C., et al. Identification of a new human coronavirus. Nat Med 2004, 10:368-373.
60. Canuti M., Eis-Huebinger A.M., Deijs M., de Vries M., Drexler J.F., Oppong S.K., et al. Two novel parvoviruses in frugivorous New and Old World bats. PLoS One 2011, 6:e29140.
61. Canuti M., Williams C.V., Gadi S.R., Jebbink M.F., Oude Munnink B.B., Jazaeri Farsani S.M., et al. Persistent viremia by a novel parvovirus in a slow loris (Nycticebus coucang) with diffuse histiocytic sarcoma. Front Microbiol 2014, 5:655.
62. Canuti M., Deijs M., Jazaeri Farsani S.M., Holwerda M., Jebbink M.F., de Vries M., et al. Metagenomic analysis of a sample from a patient with respiratory tract infection reveals the presence of a γ-papillomavirus. Front Microbiol 2014, 5:347.
63. Briese T., Kapoor A., Mishra N., Jain K., Kumar A., Jabado O.J., et al. Virome capture sequencing enables sensitive viral diagnosis and comprehensive virome analysis. MBio 2015, 6:e01491-15.
64. Ge F., Parker J., Chul Choi S., Layer M., Ross K., Jilly B., et al. Preferential amplification of pathogenic sequences. Sci Rep 2015, 5:11047.
65. de Vries M., Deijs M., Canuti M., van Schaik B.D., Faria N.R., van de Garde M.D., et al. A sensitive assay for virus discovery in respiratory clinical samples. PLoS One 2011, 6:e16118.
66. de Vries M., Oude Munnink B.B., Deijs M., Canuti M., Koekkoek S.M., Molenkamp R., et al. Performance of VIDISCA-454 in feces-suspensions and serum. Viruses 2012, 4:1328-1334.
67. Li L., Deng X., Mee E.T., Collot-Teixeira S., Anderson R., Schepelmann S., et al. Comparing viral metagenomics methods using a highly multiplexed human viral pathogens reagent. J Virol Methods 2015, 213:139-146.
68. Duhaime M.B., Deng L., Poulos B.T., Sullivan M.B. Towards quantitative metagenomics of wild viruses and other ultra-low concentration DNA samples: a rigorous assessment and optimization of the linker amplification method. Environ Microbiol 2012, 14:2526-2537.
69. Buermans H.P., den Dunnen J.T. Next generation sequencing technology: advances and applications. Biochim Biophys Acta 2014, 1842:1932-1941.
70. Widasari D.I., Yano Y., Heriyanto D.S., Utsumi T., Yamani L.N., Rinonce H.T., et al. A deep-sequencing method detects drug-resistant mutations in the hepatitis B virus in Indonesians. Intervirology 2014, 57:384-392.
71. Rego F.F., de Oliveira T., Giovanetti M., Galvão-Castro B., Gonçalves M.S., Alcantara L.C. Deep sequencing analysis of Human T cell Lymphotropic Virus type 1 (HTLV-1) long terminal repeat (LTR) 5' region from patients with Tropical Spatic Paraparesis (TSP)/HTLV-associated myelopathy (HAM) and asymptomatic carriers. AIDS Res Hum Retroviruses 2015, [Epub ahead of print].
72. Van den Hoecke S., Verhelst J., Vuylsteke M., Saelens X. Analysis of the genetic diversity of influenza A viruses using next-generation DNA sequencing. BMC Genomics 2015, 16:79.
73. Resende P.C., Motta F.C., Born P.S., Miranda M., Siqueira M.M. Whole-genome sequences of influenza A(H3N2) viruses isolated from Brazilian patients with mild illness during the 2014 season. Mem Inst Oswaldo Cruz 2015, 110:148-150.
74. Christiansen M.T., Brown A.C., Kundu S., Tutill H.J., Williams R., Brown J.R., et al. Whole-genome enrichment and sequencing of Chlamydia trachomatis directly from clinical samples. BMC Infect Dis 2014, 14:591.
75. Holmes A., Allison L., Ward M., Dallman T.J., Clark R., Fawkes A., et al. Utility of whole-genome sequencing of Escherichia coli O157 for outbreak detection and epidemiological surveillance. J Clin Microbiol 2015, 53:3565-3573.
76. Perlejewski K., Popiel M., Laskus T., Nakamura S., Motooka D., Stokowy T., et al. Next-generation sequencing (NGS) in the identification of encephalitis-causing viruses: unexpected detection of human herpesvirus 1 while searching for RNA pathogens. J Virol Methods 2015, 226:1-6.
77. Santiago-Rodriguez T.M., Ly M., Bonilla N., Pride D.T. The human urine virome in association with urinary tract infections. Front Microbiol 2015, 6:14.
78. Xia H., Hu C., Zhang D., Tang S., Zhang Z., Kou Z., et al. Metagenomic profile of the viral communities in Rhipicephalus spp. ticks from Yunnan, China. PLoS One 2015, 10:e0121609.
79. Ameur A., Meiring T.L., Bunikis I., Häggqvist S., Lindau C., Lindberg J.H., et al. Comprehensive profiling of the vaginal microbiome in HIV positive women using massive parallel semiconductor sequencing. Sci Rep 2014, 4:4398.
80. Alquezar-Planas D.E., Mourier T., Bruhn C.A., Hansen A.J., Vitcetz S.N., Mørk S., et al. Discovery of a divergent HPIV4 from respiratory secretions using second and third generation metagenomic sequencing. Sci Rep 2013, 3:2468.
81. Greninger A.L., Naccache S.N., Federman S., Yu G., Mbala P., Bres V., et al. Rapid metagenomic identification of viral pathogens in clinical samples by real-time nanopore sequencing analysis. Genome Med 2015, 7:99.
82. Smits S.L., Bodewes R., Ruiz-González A., Baumgärtner W., Koopmans M.P., Osterhaus A.D., et al. Recovering full-length viral genomes from metagenomes. Front Microbiol 2015, 6:1069.
83. Vázquez-Castellanos J.F., García-López R., Pérez-Brocal V., Pignatelli M., Moya A. Comparison of different assembly and annotation tools on analysis of simulated viral metagenomic communities in the gut. BMC Genomics 2014, 15:37.
84. Naccache S.N., Federman S., Veeraraghavan N., Zaharia M., Lee D., Samayoa E., et al. A cloud-compatible bioinformatics pipeline for ultrarapid pathogen identification from next-generation sequencing of clinical samples. Genome Res 2014, 24:1180-1192.
85. Sauvage V., Cheval J., Foulongne V., Gouilh M.A., Pariente K., Manuguerra J.C., et al. Identification of the first human gyrovirus, a virus related to chicken anemia viru. J Virol 2011, 85:7948-7950.
86. Sauvage V., Foulongne V., Cheval J., Ar Gouilh M., Pariente K., Dereure O., et al. Human polyomavirus related to African green monkey lymphotropic polyomavirus. Emerg Infect Dis 2011, 17:1364-1370.
87. Xu B., Zhi N., Hu G., Wan Z., Zheng X., Liu X., et al. Hybrid DNA virus in Chinese patients with seronegative hepatitis discovered by deep sequencing. Proc Natl Acad Sci USA 2013, 110:10264-10269.
88. Naccache S.N., Greninger A.L., Lee D., Coffey L.L., Phan T., Rein-Weston A., et al. The perils of pathogen discovery: origin of a novel parvovirus-like hybrid genome traced to nucleic acid extraction spin columns. J Virol 2013, 87:11966-11977.
89. Smuts H., Kew M., Khan A., Korsman S. Novel hybrid parvovirus-like virus, NIH-CQV/PHV, contaminants in silica column-based nucleic acid extraction kits. J Virol 2014, 88:1398.
90. ème congrès de la Société française de transfusion sanguine 2015, 201-213. Elsevier Masson. SFTS (Ed.).
91. Bosch A., Pintó R.M., Guix S. Human astroviruses. Clin Microbiol Rev 2014, 27:1048-1074.
92. Finkbeiner S.R., Holtz L.R., Jiang Y., Rajendran P., Franz C.J., Zhao G., et al. Human stool contains a previously unrecognized diversity of novel astroviruses. Virol J 2009, 6:161.
93. Holtz L.R., Wylie K.M., Sodergren E., Jiang Y., Franz C.J., Weinstock G.M., et al. Astrovirus MLB2 viremia in febrile child. Emerg Infect Dis 2011, 17:2050-2052.
94. Bouzalas I.G., Wüthrich D., Walland J., Drögemüller C., Zurbriggen A., Vandevelde M., et al. Neurotropic astrovirus in cattle with nonsuppurative encephalitis in Europe. J Clin Microbiol 2014, 52:3318-3324.
95. Quan P.L., Wagner T.A., Briese T., Torgerson T.R., Hornig M., Tashmukhamedova A., et al. Astrovirus encephalitis in boy with X-linked agammaglobulinemia. Emerg Infect Dis 2010, 16:918-925.
96. Saylor D., Thakur K., Venkatesan A. Acute encephalitis in the immunocompromised individual. Curr Opin Infect Dis 2015, 28:330-336.
97. Wunderli W., Meerbach A., Güngör T., Berger C., Greiner O., Caduff R., et al. Astrovirus infection in hospitalized infants with severe combined immunodeficiency after allogeneic hematopoietic stem cell transplantation. PLoS One 2011, 6:e27483.
98. Naccache S.N., Peggs K.S., Mattes F.M., Phadke R., Garson J.A., Grant P., et al. Diagnosis of neuroinvasive astrovirus infection in an immunocompromised adult with encephalitis by unbiased next-generation sequencing. Clin Infect Dis 2015, 60:919-923.
99. Kapoor A., Kumar A., Simmonds P., Bhuva N., Singh Chauhan L., Lee B., et al. Virome analysis of transfusion recipients reveals a novel human virus that shares genomic features with hepaciviruses and pegiviruses. MBio 2015, 6:e01466-15.
100. Uch R., Fournier P.E., Robert C., Blanc-Tailleur C., Galicher V., Barre R., et al. Divergent gemycircularvirus in HIV-positive blood, France. Emerg Infect Dis 2015, 21:2096-2098.
101. Popgeorgiev N., Boyer M., Fancello L., Monteil S., Robert C., Rivet R., et al. Marseillevirus-like virus recovered from blood donated by asymptomatic humans. J Infect Dis 2013, 208:1042-1050.
102. Popgeorgiev N., Colson P., Thuret I., Chiarioni J., Gallian P., Raoult D., et al. Marseillevirus prevalence in multitransfused patients suggests blood transmission. J Clin Virol 2013, 58:722-725.
103. Sauvage V., Livartowski A., Boizeau L., Servant-Delmas A., Lionnet F., Lefrère J.J., et al. No evidence of Marseillevirus-like virus presence in blood donors and recipients of multiple blood transfusions. J Infect Dis 2014, 210:2017-2018.
104. Phan T.G., Desnues C., Switzer W.M., Djoko C.F., Schneider B.S., Deng X., et al. Absence of giant blood Marseille-like virus DNA detection by polymerase chain reaction in plasma from healthy US blood donors and serum from multiply transfused patients from Cameroon. Transfusion 2015, 55:1256-1262.